Homepage > Company > Media > Pharma News > 2018 > Greenstone launches authorized generic of Silvadene Cream

Greenstone launches authorized generic of Silvadene Cream

Pfizer subsidiary Greenstone has introduced its authorized generic of Silvadene Cream (silver sulfadiazine cream, 1%). The drug is indicated as an adjunct to prevent and treat wound sepsis in patients with first- and second-degree burns.

Greenstone’s generic will be available in 50- and 85-g tubes, as well as in 50- and 400-g jars.

January 16, 2018

https://www.drugstorenews.com/

Read also

EC approves AstraZeneca’s Fasenra for EGPA treatment

The European Commission (EC) has approved AstraZeneca‘s Fasenra (benralizumab) as an add-on therapy for adults with relapsing or refractory eosinophilic granulomatosis with polyangii...

Genprex reports positive preclinical gene therapy data

Genprex, Inc., a clinical-stage gene therapy company, announced positive preclinical results for its lead drug candidate, Reqorsa® (quratusugene ozeplasmid) Gene Therapy, at the recent EORTC-...

Astellas withdraws Europe ACP application for AMD treatment

Astellas Pharma has announced the withdrawal of its marketing authorisation application for IZERVAY (avacincaptad pegol, ACP) intravitreal solution to treat geographic atrophy (GA) sec...

New report demands greater understanding of the impact of change on academia

Digital Science, a technology company serving stakeholders across the research ecosystem, is today calling for greater awareness of the impact that a myriad of fast-developing technologies are having ...